Four mentored undergrad research projects from Western Kentucky University were selected for the 24th Posters-at-the-Capitol on March 5, 2026, in Frankfort's Capitol Annex building.

Penn State Altoona will hold poster presentation workshops for students already registered for or interested in participating in the Undergraduate Research and Creative Activities Fair. Students may ...

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat ...

CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target ...

The Office of Graduate Studies is excited to invite graduate students to participate in our third annual Graduate Research Showcase! As part of our mission, the Office of Graduate Studies is driven to ...

Turn a simple salad into a show-stopping dish with this clever serving idea. As California highway slides toward sea, the fix will take billions Trump cites the Bible on “vulnerable children,” sparks ...

Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist’s proprietary discovery platform are currently in advanced ...

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ...

WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...

DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP1R/GCGR dual agonist for the treatment of obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH) that is to be ...

Cyclin D1 is overexpressed in certain solid tumors and hematologic malignancies. In these cancers, the cyclin D1/CDK4 complex drives cell proliferation by binding to the tumor suppressor ...

Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting PR Newswire BOULDER, Colo., Aug. 25, 2025 ...